GBX2
Homeobox protein GBX-2
Also known as: GBX2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52951
- Gene
- GBX2
- Ensembl
- ENSG00000168505
- Chromosome
- 2
- Canonical length
- 348 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of nervous system development and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including branching involved in blood vessel morphogenesis; nervous system development; and neural crest cell migration. Predicted to be located in chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
348 residues, UniProt reviewed canonical sequence.
>P52951|GBX2
1 MSAAFPPSLM MMQRPLGSST AFSIDSLIGS PPQPSPGHFV YTGYPMFMPY RPVVLPPPPP
61 PPPALPQAAL QPALPPAHPH HQIPSLPTGF CSSLAQGMAL TSTLMATLPG GFSASPQHQE
121 AAAARKFAPQ PLPGGGNFDK AEALQADAED GKGFLAKEGS LLAFSAAETV QASLVGAVRG
181 QGKDESKVED DPKGKEESFS LESDVDYSSD DNLTGQAAHK EEDPGHALEE TPPSSGAAGS
241 TTSTGKNRRR RTAFTSEQLL ELEKEFHCKK YLSLTERSQI AHALKLSEVQ VKIWFQNRRA
301 KWKRVKAGNA NSKTGEPSRN PKIVVPIPVH VSRFAIRSQH QQLEQARPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GBX2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 2.6 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 2.6 nTPM
- hypothalamus: 1.3 nTPM
- spinal cord: 1 nTPM
- cerebellum: 0.6 nTPM
- midbrain: 0.6 nTPM
- cerebral cortex: 0.3 nTPM
Single-cell type
- bergmann glia: 4.1 nCPM
- early spermatids: 3.6 nCPM
- other brain neurons: 2.7 nCPM
- ependymal cells: 2.2 nCPM
- undifferentiated spermatogonia: 1.1 nCPM
- astrocytes: 1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 32 nTPM
- midbrain: 13 nTPM
- medulla oblongata: 11 nTPM
- pons: 6.9 nTPM
- spinal cord: 6.9 nTPM
- hypothalamus: 6.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.71
- gnomAD missense Z
- 1.4
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autonomic nervous system development
- axon guidance
- branching involved in blood vessel morphogenesis
- cerebellar granule cell precursor proliferation
- cerebellum development
- forebrain neuron development
- inner ear morphogenesis
- midbrain-hindbrain boundary morphogenesis
- nervous system development
- neural crest cell migration
- regulation of nervous system development
- regulation of transcription by RNA polymerase II
- rhombomere 2 development
- thalamus development
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II core promoter sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GBX2 as an antibody target. Whether an autoantibody or antibody against GBX2 could matter depends on whether native GBX2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GBX2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GBX2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...